ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 0.1.63 (23 May 2017) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification2943210CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120180110W154deBibliographieenBibliographyfrBibliographieEP13824661.6201312202015072420160705enenen20122337020121224GB2018011020180220151118201547201710042017402017041820180110201802A61K 35/74 20150101AFI20140717BHEP A61P 9/10 20060101ALI20140717BHEP A61P 3/10 20060101ALI20140717BHEP A61P 39/06 20060101ALI20140717BHEP deLACTOBACILLUS FERMENTUM ME-3 ZUR VERWENDUNG IN DER BEHANDLUNG VON METABOLISCHEM SYNDROM VERBUNDENEN KRANKHEITENenLACTOBACILLUS FERMENTUM ME-3 FOR USE IN TREATING METABOLIC SYNDROME RELATED DISEASESfrLACTOBACILLUS FERMENTUM ME-3 POUR L'UTILSATION DANS LE TRAITEMENT DES MALADIES LIÉES AU SYNDROME MÉTABOLIQUEUS-A1- 2004 071 680US-A1- 2004 126 356US-A1- 2004 151 708MARIKA MIKELSAAR ET AL: "Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic", MICROBIAL ECOLOGY IN HEALTH AND DISEASE, vol. 101, no. 10, 1 January 2009 (2009-01-01), pages 4D-27, XP055103173, ISSN: 0891-060X, DOI: 10.1161/CIRCULATIONAHA.106.655688TIIU KULLISAAR ET AL: "An antioxidant probiotic reduces postprandial lipemia and oxidative stress", CENTRAL EUROPEAN JOURNAL OF BIOLOGY, vol. 6, no. 1, 13 November 2010 (2010-11-13), pages 32-40, XP055103171, ISSN: 1895-104X, DOI: 10.2478/s11535-010-0103-4KULLISAAR, TiiuÜlikooli 18EE-50090 TartuEEZILMER, MihkelÜlikooli 18EE-50090 TartuEESMIDT, ImbiÜlikooli 18EE-50090 TartuEEZILMER, KerstiÜlikooli 18EE-50090 TartuEEMIKELSAAR, MarikaÜlikooli 18EE-50090 TartuEEHÜTT, PirjeÜlikooli 18EE-50090 TartuEEUniversity of Tartu100246351P063006EPÜlikooli 1850090 TartuEECarpmaels & Ransford LLP101299776One Southampton RowLondon WC1B 5HAGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRIB201306121620131220enWO201410269220140703201427